No Detail Found!

Assessment of type II  diabetes mellitus drug therapy in diabetes clinic of a Tertiary Care Teaching Hospital in Addis Aababa

Author(s)
Alemseged Ayele Asfaw Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, School of Pharmacy, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia
Nahom Mulugeta Mamo Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, School of Pharmacy, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia
Abel Tesfaye Anshabo Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, School of Pharmacy, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia
Segewkal Hawaze Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, School of Pharmacy, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia
Abstract
Background: Prevalence of type II diabetes mellitus(T2DM) is substantially increasing in Ethiopia but there are no studies on its drug therapy. Objective: To assess drug therapy for T2DM and check association between fasting blood glucose levels with patient demographics, clinical characteristics and medications. Materials and Methods: A cross-sectional institution based study was conducted on T2DM patients over a 1 month period using patient chart review and key informant interview at the diabetes clinic of Tikur Anbessa Specialized Hospital (TASH). Results: Of 103 patients enrolled females accounted 59.2%. The mean age was 52.2 years and 96.12% of patients were from Addis Ababa. The mean fasting blood glucose (FBG) and body mass index (BMI) were 155.99 mg/dl and 26.4 kg/m2 respectively. About 51.45% of the patients were overweight; and neutral protamine hagedorn insuline (NPH) (56.3%), metformin plus glibenclamide (19.4%) and metformin (10.7%) were the most common drug therapies. But there was no significant association of FBG levels of patients with either, gender, age, BMI or medications. Conclusions: The drug therapy at the diabetes clinic was in line with recommendations of International Diabetes Federation (IDF)despite lack of uniform guideline.
Publication Details
Page(s) 113-118
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 5, Issue: 3, Year: 2014

Request the full text from PASTIC

Keywords
lack of uniform guideline, Fasting blood glucose, Body mass index, Ethiopia, Tikur Anbessa Specialized Hospital
0

Citations

0

Downloads

9

Views